PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15905218-15	2005	of CGRP (1.5 microg) with the mu and kappa opioid receptor-specific antagonists naloxone (10 microg) and norbinaltorphimine (5 microg), respectively, blocked the CGRP-induced suppression of LH pulses, whilst i.c.v.	norbinaltorphimine	105-123	calcitonin-related polypeptide alpha	Rattus norvegicus	3-7	
20659434-5	2010	Furthermore, the CGRP-induced antinociception is attenuated by intra-NAc injection of mu-opioid receptor (MOR) antagonist beta-funaltrexamine (beta-FNA) and kappa-opioid receptor (KOR) antagonist nor-binaltorphimine (nor-BNI), but not by delta-receptor (DOR) antagonist naltrindole.	norbinaltorphimine	217-224	calcitonin-related polypeptide alpha	Rattus norvegicus	17-21	
15905218-15	2005	of CGRP (1.5 microg) with the mu and kappa opioid receptor-specific antagonists naloxone (10 microg) and norbinaltorphimine (5 microg), respectively, blocked the CGRP-induced suppression of LH pulses, whilst i.c.v.	norbinaltorphimine	105-123	calcitonin-related polypeptide alpha	Rattus norvegicus	162-166	
8389648-7	1993	In contrast, intrathecal perfusion with naloxone (10 microM) or nor-binaltorphimine (10 microM), a selective antagonist of kappa receptors, produced a marked increase in spinal CGRPLM release, suggesting that endogenous opioids acting at mu and kappa receptors, respectively, exert a tonic inhibitory control of CGRP-containing fibers.	norbinaltorphimine	64-83	calcitonin-related polypeptide alpha	Rattus norvegicus	177-181